DPath

AI and digital pathology, owned in Singapore

Digital pathology.
Regional expertise.

DPath owns the AI models and scanner technology behind its digital pathology products. We bring them to hospitals, clinics and researchers across Southeast Asia from our home in Singapore.

Explore solutions Our technology
Concept illustration of glass pathology slides following a translucent blue pathway.
Digital pathology, connected. Concept illustration
  • ProprietaryAI and scanner technology
  • 11Southeast Asian markets
  • 4Pathology and research products
  • 1Regional point of contact
Technology owned byDPath

Our own AI and scanner technology.
Owned and controlled in Singapore.

DPath PTE LTD holds sole ownership of the AI models, software and scanner designs behind its products.

Built around the work you do.

From the pathology lab to the research team, find the right starting point for your organisation.

Pathology departments

Connect specimen tracking, digital scanning and pathologist review in a considered lab workflow.

  • Specimen-to-report traceability
  • Slide scanning and image quality control
  • Integration with existing hospital systems
Explore DPath OnePIS & DPath DX

Clinics & care networks

A planned clinic configuration for scanning prepared slides and generating visual AI assistance for clinician review.

  • Tissue biopsy and cytology evaluated separately
  • Local validation for each intended use
  • Designed to work with existing preparation providers
Discuss a clinic partnership

CareSpace: Agent managed workspace

Bring records, case timelines and model outputs into a disease-focused workspace for clinician review.

  • IBD as the first development focus
  • Source-linked records and review tasks
  • Demonstrations using synthetic data
Explore CareSpace

Research & biopharma

Scope a study around pathology quantification, multimodal analysis and reproducible evidence.

  • Study feasibility and cohort preparation
  • Image analysis and expert review
  • Project services independent of equipment purchase
Discuss a research project
Concept illustration of glass slides and a digital scanning line.
A connected view of the pathology workflow. Concept illustration

The DPath portfolio

Four products. One connected foundation.

Complementary tools for pathology, clinical review and research, built on DPath-owned AI and scanner technology. Explore each product’s role and current development stage.

Design & engineering

Pathology operations

DPath OnePIS

Keep specimens, slides and departmental tasks connected, from registration to structured report drafts.

Product details

Designed for specimen registration, slide flow traceability, history summaries and department task management. Standalone or integrated deployment depends on the hospital’s existing systems.

Planning your project: workflow scope, system integration and acceptance criteria are agreed with your hospital.

Ask about DPath OnePIS
Hardware & software integration

Digital pathology foundation

DPath DX

Connect DPath’s slide scanner, image quality control and model execution in a shared technical foundation.

Product details

Built around slide ingestion, model deployment and permission auditing, with distinct pathology and clinical configurations. Integration is progressing from a research prototype.

Planning your project: scanner configuration, installation, maintenance and acceptance requirements are set in the delivery agreement.

Ask about DPath DX
Synthetic-data demonstration

Agent managed workspace

CareSpace

Put model outputs into the context of the whole case, with source-linked records and clinician review.

Product details

A disease-focused workspace for structured records, case timelines and review tasks. IBD is the near-term development focus; existing demonstrations use synthetic data.

Planning your project: deployment is envisaged on the hospital network or in a controlled environment. The responsible clinician reviews medical decisions.

Ask about CareSpace
Platform planned

Research & evidence

DPath Studio

Bring analysis, expert review and reproducible evidence together for hospital and biopharma studies.

Product details

A planned analysis and evidence-delivery platform. Hospital research is initially supported through project-based services; platform licensing is introduced as reuse stabilises.

Planning your project: data permissions, study outputs and intellectual property are scoped separately for each engagement.

Ask about DPath Studio

Product stage, commercial availability and regulatory authorisation are assessed separately. DPath will confirm the applicable configuration and local requirements for your project.

Technology ownership

Our technology.
Owned in Singapore.

DPath PTE LTD holds sole and exclusive ownership of the intellectual property developed for its products.

Customers work with the company that owns what they deploy. DPath controls the product roadmap, how its technology is protected and the clinical evidence built around it.

Talk to DPath

Rooted in Singapore.
Focused on Southeast Asia.

A regional conversation, grounded in your local needs.

DPath brings its own products to organisations across Southeast Asia. Start with your country, your workflow and the outcome you want to achieve.

Market by marketLocal requirements and intended use shape each project.

One accountable companyProduct evaluation, commercial terms and long-term support sit with the company that owns the technology.

Explore a regional partnership
Map of Southeast Asia with Singapore marked as DPath’s base.
SingaporeMalaysiaIndonesiaThailandVietnamPhilippinesBruneiCambodiaLaosMyanmarTimor-Leste

Regional sales territory. Availability is confirmed by market.

About DPath

Good technology starts
with the right conversation.

DPath PTE LTD is a Singapore company that owns the AI models, software and scanner technology behind its products.

We bring that technology to hospitals, clinics and research teams across Southeast Asia, and help each organisation define a project that fits its workflow and local requirements.

We also offer Polaris, our healthcare webapp for patients, families and caregivers.

Whether you are evaluating a pathology workflow, discussing a study or building a clinic partnership, we start by understanding the work.

Explore the DPath portfolio

  1. Understand the work

    Your country, workflow and the outcome you want to achieve.

  2. Shape the project

    Match the right product, research scope or partnership model.

  3. Deliver and support

    Agree configuration, local requirements, validation and ongoing support with DPath.

A few useful answers.

Clarity before the next step.

What is Polaris, and how do I access it?

Polaris is DPath’s healthcare webapp for patients, families and caregivers. Visit polaris.dpath.ai (opens in a new tab) to get started or sign in.

Who owns the technology in DPath’s products?

DPath PTE LTD, a Singapore company, holds sole ownership of the project-specific intellectual property in its products. This includes AI models and trained weights, algorithms, source code, training pipelines, scanner designs, firmware and software integrations. Where third-party technology is built in, licences cover modification, commercialisation and ongoing product support.

Are all products ready for clinical use?

No. The portfolio includes products at design, integration, demonstration and planned stages. Clinical use depends on the specific product, intended use, validation and applicable local authorisation. A demonstration or development milestone does not establish regulatory approval.

Can research services be discussed without buying equipment?

Yes. DPath’s hospital research services can be scoped independently of equipment purchases. Share your research question, available data and intended outputs so the project team can assess feasibility.

What does the planned clinic configuration do?

It is intended to scan already-prepared slides and generate model-assisted review information for clinicians. It does not prepare tissue or replace a clinician’s diagnosis. Tissue biopsy and Pap or liquid-based cytology follow separate validation routes. Routine delivery does not include a remote pathologist review service.

How should we approach patient data?

Start with a non-identifiable description of your project. Data access, storage, transfer and permitted uses must be agreed for the specific study, organisation and country before any patient data is shared. Please do not send patient records through this website or an initial inquiry.

Let’s find your
path forward.

Tell us what you’re working on. We’ll start with the right product, project or partnership conversation.

contact@dpath.ai

DPath PTE LTD
Singapore

Prefer email? Write to us directly, or use this form to prepare an inquiry in your email app.

Please don’t include patient data. This form prepares an email on your device. Nothing is submitted to DPath until you send it. Privacy notice